$NCSM

Nipper Robert sold (to issuer) 88,596 shares of NCSM (indirect holdings)

Nipper Robert sold (to issuer) 88,596 indirectly-held shares of NCS Multistage Holdings, Inc. (NCSM) on 2026-09-01.

Original reporting
SEC EDGAR · Nipper Robert
Published Sep 1, 2026, 1:54 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 1, 2026, 2:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NCSM
Bearish
medium confidence
Mentioned
$NCSM
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NCSMBearishLow
01

Why it matters

The director's complete exit may affect market perception of NCSM's prospects.

02

Market read

The filing provides fresh insider activity data, modestly relevant for short-term traders.

03

What to watch

Absence of a 10b5-1 plan and the director's remaining stake being zero may indicate a strategic exit.

Relevance 4/10Novelty 4/10Timing: filing date 2026-09-01

Background

SEC Form 4 filing discloses insider transactions for public companies.

Company-level read

Ticker impact

$NCSMBearishMedium confidence
Context

Director Robert Nipper sold 88,596 shares of NCS Multistage Holdings, reducing his holdings to zero.

Expected impact

Potential modest decline in share price over the next few days.

Evidence & confidence

Director-level insider sold a sizable block without a 10b5-1 plan, indicating a discretionary decision.

Market effects

Minimal impact on the broader sector; the sale is company-specific.

No significant regional effect.

Limited to investors tracking NCSM.

Counterpoint

The sale could be a routine portfolio rebalancing rather than a negative signal.

Key entities

  • NCS Multistage Holdings, Inc.

    Issuer of the Form 4 filing.

  • Robert Nipper

    Director of NCSM who sold his shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SIONMed

RA CAPITAL MANAGEMENT, L.P. (Kolchinsky Peter, Shah Rajeev M.) sold $21.8M of SION (indirect holdings)

RA CAPITAL MANAGEMENT, L.P. sold 3,448,811 indirectly-held shares of Sionna Therapeutics, Inc. (SION) at an average of $6.33 ($6.32–$7.46, $21.84M total) across 2 trades on 2026-09-17. Filed jointly with RA Capital Healthcare Fund LP (Director), RA Capital Nexus Fund, L.P. (Director), RA Capital Nexus Fund III, L.P. (Director), Kolchinsky Peter (Director) and Shah Rajeev M. (Director).